vs
趣店(HTT)与INVO Fertility, Inc.(IVF)财务数据对比。点击上方公司名可切换其他公司
INVO Fertility, Inc.的季度营收约是趣店的1.6倍($1.8M vs $1.1M),趣店净利率更高(239.8% vs -150.5%,领先390.3%)
趣店集团是中国本土金融科技服务提供商,核心业务涵盖小额消费信贷解决方案输出、风险管理技术服务及相关数字金融产品供应,主要服务国内广大年轻消费群体,业务布局集中于中国内地市场。
INVO Fertility是一家专注于辅助生殖医疗解决方案的企业,核心产品为专利INVOcell阴道内培养装置,服务北美、欧洲等地区的生殖诊所与患者,致力于降低生育治疗门槛,为有需求的群体提供可负担的生殖医疗服务。
HTT vs IVF — 直观对比
营收规模更大
IVF
是对方的1.6倍
$1.1M
净利率更高
HTT
高出390.3%
-150.5%
损益表 — Q3 FY2024 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.1M | $1.8M |
| 净利润 | $2.6M | $-2.6M |
| 毛利率 | 11.1% | — |
| 营业利润率 | -121.7% | -93.1% |
| 净利率 | 239.8% | -150.5% |
| 营收同比 | — | 22.6% |
| 净利润同比 | — | -62.2% |
| 每股收益(稀释后) | $0.01 | $-0.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HTT
IVF
| Q3 25 | — | $1.8M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $1.6M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $1.1M | $1.4M | ||
| Q2 24 | $1.0M | $1.8M | ||
| Q1 24 | $1.1M | $1.6M | ||
| Q4 23 | — | $1.4M |
净利润
HTT
IVF
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-5.3M | ||
| Q1 25 | — | $-17.4M | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | $2.6M | $-1.6M | ||
| Q2 24 | $1.9M | $-2.2M | ||
| Q1 24 | $-1.4M | $-1.6M | ||
| Q4 23 | — | $-2.0M |
毛利率
HTT
IVF
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 41.4% | ||
| Q3 24 | 11.1% | 31.0% | ||
| Q2 24 | 13.3% | 53.1% | ||
| Q1 24 | — | 45.3% | ||
| Q4 23 | — | 33.0% |
营业利润率
HTT
IVF
| Q3 25 | — | -93.1% | ||
| Q2 25 | — | -160.4% | ||
| Q1 25 | — | -1042.1% | ||
| Q4 24 | — | -202.0% | ||
| Q3 24 | -121.7% | -90.7% | ||
| Q2 24 | -107.6% | -100.9% | ||
| Q1 24 | -129.9% | -95.7% | ||
| Q4 23 | — | -109.2% |
净利率
HTT
IVF
| Q3 25 | — | -150.5% | ||
| Q2 25 | — | -283.6% | ||
| Q1 25 | — | -1060.1% | ||
| Q4 24 | — | -211.3% | ||
| Q3 24 | 239.8% | -113.8% | ||
| Q2 24 | 187.1% | -122.2% | ||
| Q1 24 | -131.8% | -101.3% | ||
| Q4 23 | — | -144.4% |
每股收益(稀释后)
HTT
IVF
| Q3 25 | — | $-0.77 | ||
| Q2 25 | — | $-13.30 | ||
| Q1 25 | — | $-12.53 | ||
| Q4 24 | — | $14.86 | ||
| Q3 24 | $0.01 | $-15.11 | ||
| Q2 24 | $0.01 | $-22.39 | ||
| Q1 24 | $-0.01 | $-7.55 | ||
| Q4 23 | — | $-59.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $104.9M | — |
| 总债务越低越好 | — | $2.0M |
| 股东权益账面价值 | $225.2M | $5.8M |
| 总资产 | $246.8M | $18.8M |
| 负债/权益比越低杠杆越低 | — | 0.34× |
8季度趋势,按日历期对齐
现金及短期投资
HTT
IVF
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $104.9M | — | ||
| Q2 24 | $112.8M | — | ||
| Q1 24 | $140.6M | — | ||
| Q4 23 | — | — |
总债务
HTT
IVF
| Q3 25 | — | $2.0M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
股东权益
HTT
IVF
| Q3 25 | — | $5.8M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | — | $12.7M | ||
| Q3 24 | $225.2M | $-23.3K | ||
| Q2 24 | $217.5M | $1.4M | ||
| Q1 24 | $218.9M | $10.2K | ||
| Q4 23 | — | $892.8K |
总资产
HTT
IVF
| Q3 25 | — | $18.8M | ||
| Q2 25 | — | $19.3M | ||
| Q1 25 | — | $31.7M | ||
| Q4 24 | — | $46.4M | ||
| Q3 24 | $246.8M | $17.0M | ||
| Q2 24 | $227.9M | $17.8M | ||
| Q1 24 | $234.9M | $17.3M | ||
| Q4 23 | — | $18.5M |
负债/权益比
HTT
IVF
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 1.83× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.59× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-1.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.8M |
| 自由现金流率自由现金流/营收 | — | -101.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-7.8M |
8季度趋势,按日历期对齐
经营现金流
HTT
IVF
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $-617.4K | ||
| Q3 24 | — | $-640.8K | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-260.6K | ||
| Q4 23 | — | $-714.9K |
自由现金流
HTT
IVF
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-1.7M | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | — | $-696.3K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-310.3K | ||
| Q4 23 | — | — |
自由现金流率
HTT
IVF
| Q3 25 | — | -101.6% | ||
| Q2 25 | — | -92.6% | ||
| Q1 25 | — | -216.9% | ||
| Q4 24 | — | -40.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -82.3% | ||
| Q1 24 | — | -19.7% | ||
| Q4 23 | — | — |
资本支出强度
HTT
IVF
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 3.2% | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图